Incyte INCY
NASDAQ INCY
$127.78 -0.22 (-0.17%)
As of: Sep 4, 2026 · 12:52 PM EDT

Incyte (INCY) Invested Capital (2012 - 2026)

Incyte's (INCY) quarterly Invested Capital came in at $38.8 million in Q2 2026, down 17.14% YoY from $46.8 million in Q2 2025, and down 1.45% on a QoQ basis from $39.4 million in Q1 2026.

Analysis

Incyte (INCY) Invested Capital (2012 - 2026) Analysis & Trends

Incyte (INCY) has 14 years of Invested Capital data on file, last reported at $38.8 million in Q2 2026.

  • Quarterly Invested Capital fell 17.14% year-over-year to $38.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $158.5 million (down 4.99% YoY) and the FY2025 annual result came in at $34.7 million, down 8.55% from the prior year.
  • Invested Capital fell to $38.8 million in Q2 2026, from $39.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $46.8 million in Q2 2025 to a low of $32.6 million in Q4 2023.
  • A 5-year average of $38.1 million and a median of $37.3 million in 2023 frame the typical range for Invested Capital.
  • Annual changes were most pronounced in 2025 — Invested Capital advanced 26.07% — and 2026, when it fell 17.14%.
  • Tracing INCY's Invested Capital over 5 years: stood at $33.3 million in 2022, then dropped by 1.99% to $32.6 million in 2023, then climbed by 16.44% to $38.0 million in 2024, then dropped by 8.55% to $34.7 million in 2025, then gained by 11.8% to $38.8 million in 2026.
  • The last three Invested Capital figures came in at $38.8 million (Q2 2026), $39.4 million (Q1 2026), and $34.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.52 Bn 27.68 Bn - 19.13 Bn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 1.30 Bn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn 6.38 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.38 Bn
Mar 31, 2026 5.66 Bn
Dec 31, 2025 5.21 Bn
Sep 30, 2025 4.70 Bn
Jun 30, 2025 4.22 Bn
Mar 31, 2025 3.71 Bn
Dec 31, 2024 3.49 Bn
Sep 30, 2024 3.21 Bn
Jun 30, 2024 3.03 Bn
Mar 31, 2024 5.43 Bn
Dec 31, 2023 5.23 Bn
Sep 30, 2023 4.97 Bn
Jun 30, 2023 4.78 Bn
Mar 31, 2023 4.50 Bn
Dec 31, 2022 4.41 Bn
Sep 30, 2022 4.26 Bn
Jun 30, 2022 4.12 Bn
Mar 31, 2022 3.90 Bn
Dec 31, 2021 3.81 Bn
Sep 30, 2021 3.19 Bn